AutoGrid, the distributed energy management platform backed by Stanford, will use the capital from the Eon, CLP, Innogy, Total, Ørsted and Tenaska-backed round to boost hiring.
Existing backers AstraZeneca and Johnson & Johnson returned for a round that will advance PhaseBio's orphan disease drug pipeline, based on research from Duke University.
MIT spinout Formlabs has achieved unicorn status after obtaining $15m from New Enterprise Associates.
ETH Zurich and University of Zurich spinout InSphero has now raised $35m and will commercialise its organ-on-a-chip technology.
UC Investment Office, an existing Constellation backer, has returned to contribute to a $100m round that took its total equity funding to $229m.